Coding and Non-Coding RNA Abnormalities in Bipolar Disorder.
alternative splicing
bipolar disorder
cEPHA3
circular RNA
histone H3-K4 demethylation
long non-coding RNA
sequencing
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
19 11 2019
19 11 2019
Historique:
received:
17
09
2019
revised:
05
11
2019
accepted:
15
11
2019
entrez:
23
11
2019
pubmed:
23
11
2019
medline:
6
5
2020
Statut:
epublish
Résumé
The molecular mechanisms underlying bipolar disorder (BPD) have remained largely unknown. Postmortem brain tissue studies comparing BPD patients with healthy controls have produced a heterogeneous array of potentially implicated protein-coding RNAs. We hypothesized that dysregulation of not only coding, but multiple classes of RNA (coding RNA, long non-coding (lnc) RNA, circular (circ) RNA, and/or alternative splicing) underlie the pathogenesis of BPD. Using non-polyadenylated libraries we performed RNA sequencing in postmortem human medial frontal gyrus tissue from BPD patients and healthy controls. Twenty genes, some of which not previously implicated in BPD, were differentially expressed (DE). PCR validation and replication confirmed the implication of these DE genes. Functional in silico analyses identified enrichment of angiogenesis, vascular system development and histone H3-K4 demethylation. In addition, ten lncRNA transcripts were differentially expressed. Furthermore, an overall increased number of alternative splicing events in BPD was detected, as well as an increase in the number of genes carrying alternative splicing events. Finally, a large reservoir of circRNAs populating brain tissue not affected by BPD is described, while in BPD altered levels of two circular transcripts, cNEBL and cEPHA3, are reported. cEPHA3, hitherto unlinked to BPD, is implicated in developmental processes in the central nervous system. Although we did not perform replication analyses of non-coding RNA findings, our findings hint that RNA dysregulation in BPD is not limited to coding regions, opening avenues for future pharmacological investigations and biomarker research.
Identifiants
pubmed: 31752442
pii: genes10110946
doi: 10.3390/genes10110946
pmc: PMC6895892
pii:
doi:
Substances chimiques
Biomarkers
0
RNA, Circular
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Oncotarget. 2016 Nov 1;7(44):71087-71098
pubmed: 27661005
Neuropsychiatr Dis Treat. 2016 Jul 11;12:1687-703
pubmed: 27468233
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Cell Stem Cell. 2013 May 2;12(5):616-28
pubmed: 23583100
Mol Cell. 2014 Oct 2;56(1):55-66
pubmed: 25242144
Nat Med. 2008 Jul;14(7):723-30
pubmed: 18587408
Stroke. 2011 Oct;42(10):2932-9
pubmed: 21836090
Genome. 2013 Oct;56(10):634-40
pubmed: 24237345
Mol Psychiatry. 2016 Nov;21(11):1490-1498
pubmed: 27480490
Nat Rev Drug Discov. 2014 Jan;13(1):39-62
pubmed: 24378802
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Ann Neurol. 2013 Jul;74(1):20-38
pubmed: 23686809
Nat Genet. 2011 Sep 18;43(10):977-83
pubmed: 21926972
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Nat Neurosci. 2015 Apr;18(4):603-610
pubmed: 25714049
Mol Brain. 2013 Jul 08;6:31
pubmed: 23835137
Mol Psychiatry. 2016 Jul;21(7):885-93
pubmed: 27217147
Trends Neurosci. 2016 Sep;39(9):597-604
pubmed: 27445124
Genome Biol. 2016 Apr 14;17:67
pubmed: 27081004
Int J Neuropsychopharmacol. 2016 Apr 20;19(4):null
pubmed: 26371183
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Cell. 2014 Sep 25;159(1):134-147
pubmed: 25242744
Bioinformatics. 2007 Jan 15;23(2):257-8
pubmed: 17098774
Mol Psychiatry. 2017 Mar;22(3):441-449
pubmed: 27350034
Eur Neuropsychopharmacol. 2012 Feb;22(2):100-13
pubmed: 21820878
Curr Treat Options Psychiatry. 2016;3(4):315-329
pubmed: 27867834
PLoS Comput Biol. 2014 Mar 20;10(3):e1003517
pubmed: 24651478
Genome Biol. 2010;11(2):R14
pubmed: 20132535
Bipolar Disord. 2011 Feb;13(1):1-15
pubmed: 21320248
RNA. 2014 Dec;20(12):1829-42
pubmed: 25404635
Am J Psychiatry. 2015 Nov 1;172(11):1131-40
pubmed: 26238605
Am J Med Genet B Neuropsychiatr Genet. 2005 Jul 5;136B(1):12-25
pubmed: 15892139
Science. 2018 Feb 9;359(6376):693-697
pubmed: 29439242
Genome Biol. 2010;11(3):R25
pubmed: 20196867
PLoS One. 2011;6(7):e21800
pubmed: 21789182
F1000Res. 2016 Jun 20;5:1438
pubmed: 27508061
BMC Neurosci. 2010 Feb 05;11:14
pubmed: 20137068
Mol Cancer. 2017 Jan 31;16(1):25
pubmed: 28143578
Mol Psychiatry. 2016 Mar;21(3):376-85
pubmed: 26077692
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Mol Cell. 2015 Jun 4;58(5):870-85
pubmed: 25921068
JAMA Psychiatry. 2016 Jun 1;73(6):590-7
pubmed: 27120077
Genome Biol. 2015 Nov 05;16:245
pubmed: 26541409
Br J Psychiatry. 2003 Oct;183:282-4
pubmed: 14519603
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Curr Drug Targets. 2015;16(10):1021-30
pubmed: 26028047
Pharmacol Rev. 2013 Jan 08;65(1):105-42
pubmed: 23300133
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39
pubmed: 16469371
J Mol Neurosci. 2013 Mar;49(3):589-93
pubmed: 22949041
Lancet. 2013 May 11;381(9878):1654-62
pubmed: 23663951
J Affect Disord. 2013 Sep 25;150(3):727-35
pubmed: 23830141
Bipolar Disord. 2017 Mar;19(2):74-83
pubmed: 28444949
Cell. 2009 Feb 20;136(4):629-41
pubmed: 19239885
Cell. 2011 Apr 15;145(2):178-81
pubmed: 21496640
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Methods Mol Biol. 2016;1402:243-254
pubmed: 26721496
BMC Bioinformatics. 2014 Mar 23;15:81
pubmed: 24655717
Mol Psychiatry. 2010 Aug;15(8):868-76
pubmed: 19337207
Transl Psychiatry. 2014 Sep 30;4:e450
pubmed: 25268254
Hum Mol Genet. 2016 Aug 1;25(15):3383-3394
pubmed: 27329760
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Nature. 2011 May 19;473(7347):372-5
pubmed: 21508957
Mol Psychiatry. 2014 Nov;19(11):1179-85
pubmed: 24393808
Transl Psychiatry. 2014 Mar 04;4:e366
pubmed: 24594777
Lancet. 2016 Mar 12;387(10023):1085-1093
pubmed: 26806518